Trade Adaptive Biotechnologies Corporation - ADPT CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.14
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021568 %(-$0.43)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.02157%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000654 %(-$0.01)Trade size with leverage ~ $2,000.00Money from leverage ~ $1,000.00Go to platform: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021568 %
  (-$0.43)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000654 %
  (-$0.01)

Key Stats

• Prev. Close: 23.56
• Open: 24.33
• 1-Year Change: 108.3%
• Day's Range: 24.29 - 24.81

Trade Adaptive Biotechnologies Corporation - ADPT

What is Adaptive Biotechnologies Corporation (ADPT)?

Adaptive Biotechnologies Corporation is a biotechnology company focused on developing immune-driven medicine through the analysis of the adaptive immune system. The company utilizes proprietary immune profiling technology to decode the genetic sequences of T-cell and B-cell receptors. This approach enables the identification of disease-specific immune signatures, which can be applied in diagnostics, therapeutics, and research. Adaptive Biotechnologies collaborates with pharmaceutical companies and research institutions to advance the understanding of immune responses in various diseases, including cancer, autoimmune disorders, and infectious diseases. Its platform supports the development of novel diagnostic tests and personalized treatment strategies. The company operates at the intersection of immunology and genomics, leveraging high-throughput sequencing and machine learning. Adaptive Biotechnologies aims to transform immune system data into actionable clinical insights, contributing to precision medicine advancements.

Adaptive Biotechnologies Corporation Stock Price Today: Live Overview

The price today is shaped by trading fluctuations, as Adaptive Biotechnologies Corporation trades at $24.93. Intraday values have ranged from $24.06 to $24.71, with a daily change of +4.9425%.

FAQ: Adaptive Biotechnologies Corporation (ADPT)

What is the current price of ADPT stock?

Adaptive Biotechnologies Corporation's last traded price is $24.93.

Does ADPT pay dividends?

Adaptive Biotechnologies Corporation does not pay dividends.

Does ADPT have a formal corporate presence or regional headquarters in the UAE?

Adaptive Biotechnologies Corporation operates via partners and distributors in the UAE without an official regional office or subsidiary.

What is ADPT best known for?

Adaptive Biotechnologies Corporation is most famous for its immune-driven diagnostics and therapeutics.

What assets are typically shown together with ADPT?

Commonly shown alongside ADPT: iShares MSCI Japan UCITS ETF, Matson Inc, Investors Title Co